InvestorsHub Logo
Followers 826
Posts 119567
Boards Moderated 14
Alias Born 09/05/2002

Re: Boing x 2 post# 14598

Wednesday, 09/30/2015 3:17:14 PM

Wednesday, September 30, 2015 3:17:14 PM

Post# of 20689
My 3Q15 Glatopa estimates in #msg-116782888 ($104M in-market sales; $41.5M revenue to MNTA) may be too high, based on the recent script data. However, I’m sticking with the above numbers (for now) because the scripts reported by IMS and Symphony can be unreliable for generic drugs.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”